Endogenous / BiologyEndogenousHuman-supportedUpdated 2026-04-24

Peptide reference file

PYY

Trending #18 in Endogenous8.4k searches/moProven

Peptide YY is an endogenous gut hormone involved in satiety and appetite regulation after food intake.

Current readout: human-supported evidence, endogenous status, endogenous approval state, human evidence appears in the current trail, registered trials are linked, and 3 linked sources in the seed trail.

PubChem CID 126455957 | 4600 PubMed results | 81 trial records | 0 DailyMed labels | 0 Drugs@FDA applications

PYY is mostly discussed because it helps explain the broader appetite-biology landscape beyond GLP-1 alone.

The public claim is straightforward: It helps explain the broader appetite-biology landscape beyond GLP-1 alone. High-relevance human appetite biology with indirect translational value.

In plain language, peptide YY is an endogenous gut hormone involved in satiety and appetite regulation after food intake.

Human-supportedEndogenous
Gut hormoneSatiety signalingAppetite regulation

Aliases: Peptide YY

SpecimenPYY specimen
CCCCCHHHHHHHNO
Formula
C194H295N55O57
Mass
4310
Evidence
Human-supported
Elements
4

Most commonly discussed in relation to Gut hormone, Satiety signaling, Appetite regulation.

What PYY is

Peptide YY is an endogenous gut hormone involved in satiety and appetite regulation after food intake.

PYY is grouped under Endogenous / Biology / Fat Loss + GLP-1s on PeptideFactCheck because it helps explain the broader appetite-biology landscape beyond GLP-1 alone.

The useful starting point is to separate the molecule itself from the internet story around it. It helps explain the broader appetite-biology landscape beyond GLP-1 alone.

Why people keep looking it up

It helps explain the broader appetite-biology landscape beyond GLP-1 alone.

Peptide YY is an endogenous gut hormone involved in satiety and appetite regulation after food intake.

PYY tends to stay in the conversation because it touches a familiar public theme: gut hormone, satiety signaling, and appetite regulation. That makes it easy for the claim to travel faster than the evidence.

What the evidence can support right now

High-relevance human appetite biology with indirect translational value.

Human physiology is well established, though that does not automatically translate into a product-level peptide intervention story.

Mechanistic support across gut-hormone and satiety biology is strong.

Why this page carries the current tier: High-relevance human appetite biology with indirect translational value.

The current seed trail for PYY is pulling from 2 databases sources and 1 literature source.

Safety, limits, and regulatory context

Native satiety biology and commercial peptide claims should be kept separate.

PYY is tracked here as endogenous biology rather than an approved peptide drug.

Editorial boundary: PeptideFactCheck does not publish dosing, cycling, sourcing, injection, or administration instructions for PYY. The job here is to explain the public claim, the mechanism story, the evidence strength, and the current limits.

Molecular and identifier data

The current PubChem match for PYY is CID 126455957. That gives the page a source-backed chemistry record rather than a placeholder identifier block.

PubChem CID
126455957
Formula
C194H295N55O57
Molecular weight
4310
InChIKey
YNXLOPYTAAFMTN-SBUIBGKBSA-N

Matched synonyms include Peptide yy human, 118997-30-1, Peptide YY [MI], Peptide yy (1-36), PYY (1-36) peptide, Peptide YY (human) trifluoroacetate salt, PYY, UNII-T2670C12I5.

Open PubChem record

Clinical trial snapshot

The current ClinicalTrials.gov intervention query for PYY returns 81 study records. This does not prove efficacy by itself, but it does show whether the peptide is showing up in a formal trial registry rather than only in forums or vendor copy.

Literature snapshot

The current PubMed query for PYY returns 4600 results. The articles below are a quick literature surface so the page shows actual papers instead of only generic evidence labels.

Source trail

Each linked source is shown directly so the page can be audited. The page now combines its editorial seed trail with automated official-source enrichment generated on 2026-04-24 from PubChem, ClinicalTrials.gov, PubMed, DailyMed, openFDA label, and Drugs@FDA.

Safety noteThis content is educational only and does not replace medical advice. Peptide use may carry risks and should be discussed with a qualified medical professional.